The #1 Early Sign of Osteoporosis Most People Miss, According to Orthopedists first appeared on Parade on Jul 3, 2025 This ...

European Commission Approves Biocon Biologics’ Denosumab BiosimilarsBengaluru, Karnataka, India, July 3, 2025 Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary ...

Najpierw wprowadzenie podatku akcyzowego na saszetki nikotynowe, potem propozycja przepisów, które zmierzają do wycofania tych produktów z rynku – przedstawiciele środowisk ...

Biocon Biologics was granted marketing authorisation by the European Commission for Vevzuo and Evfraxy biosimilars of Denosumab used in the treatment of different bone diseases.

California lawmakers introduced bills to increase doctors' menopause training. ( NPR) The majority of people in the U.S. who ...

Standard first-line drug therapies for the treatment of bone density disorders have been linked to higher risk of experiencing a cardiovascular event, according to a study published June 26 in Epic ...